Xcout IntelCalciMedica, Inc. competitors & alternatives
The 12 closest competitors and alternatives to CalciMedica, Inc. among biotech companies — ranked by similarity to what CalciMedica, Inc. actually does, not by market-cap band.
Subscribe to see CalciMedica, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About CalciMedica, Inc.
CalciMedica, Inc., a clinical-stage biotechnology company headquartered in La Jolla, California, is focused on creating treatments for life-threatening inflammatory diseases that currently lack adequate therapies. The company's proprietary approach involves blocking calcium release-activated (CRAC) channels, a mechanism designed to modulate the immune system and protect against cellular and tissue damage in these severe conditions. Their primary experimental drug, Auxora, is an intravenously administered, proprietary CRAC channel inhibitor being developed for the treatment of acute pancreatitis, including its asparaginase-associated form, and acute kidney injury.
CalciMedica, Inc. at a glance
CalciMedica, Inc. is a biotech company headquartered in La Jolla, United States, founded in 2006. It is publicly listed (CALC) with a market capitalisation of $6M. Xcout tracks 19 named people at CalciMedica, Inc., including A. Rachel Leheny (Chief Executive Officer & Director).
CalciMedica, Inc. leadership
- A. Rachel LehenyChief Executive Officer & Director
- Michael J. DunnPresident & Chief Operating Officer
- Stephen BardinChief Financial Officer
- Sudarshan HebbarChief Medical Officer
- Eric W. RobertsChief Business Officer & Vice Chairman of the Board
- Kenneth A. StaudermanCo-Founder & Chief Scientific Officer
13 more named people on record for CalciMedica, Inc., with roles, board committees and tenure — see the full roster →
CalciMedica, Inc. funding rounds on record
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $9M | — | |
| Series B | $5.5M | — |
Some filings are not shown as funding rounds.
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 CalciMedica, Inc. competitors
Ranked by semantic similarity — how close each company is to CalciMedica, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for inflammatory and autoimmune diseases. Headquartered in California, the company advances a robust clinical pipeline and operates as a publicly traded enterprise.
Life Sciences
Crystalys Therapeutics is a biotechnology research company headquartered in San Diego, California, dedicated to developing novel therapies to address significant unmet medical needs.
Life Science
Angiocrine Bioscience, Inc. is a private, clinical-stage biotechnology company based in San Diego, California, that develops engineered endothelial cell therapies.
Similar biotech company
Calliditas Therapeutics AB is a commercial-stage biopharma company based in Stockholm, Sweden. It focuses on developing and commercializing pharmaceutical products.
Biotechnology
Cellics Therapeutics, Inc. is a privately held biotechnology company headquartered in San Diego, California, developing novel therapeutic products.
Biotechnology
Zura Bio Limited is a clinical-stage biotechnology company headquartered in San Diego, California, dedicated to pioneering new therapeutic solutions for immune system and inflammatory diseases. Its key product candidates include ZB-168, an anti-IL7Rα inhibitor engineered to address conditions influenced by the IL7 and TSLP biological pathways. The company is also advancing Torudokimab, a monoclonal antibody that neutralizes IL-33, which is currently in Phase 2 clinical development.
Similar biotech company
Unicycive Therapeutics, Inc. is a U.S.-based biotechnology company dedicated to the creation of innovative treatments for kidney diseases. Its development pipeline includes Renazorb, a therapy for hyperphosphatemia in chronic kidney disease patients, and UNI 494, which is being developed to treat acute kidney injury. Founded in 2016, the firm is headquartered in Los Altos, California.
Biotechnology
Autobahn Therapeutics, Inc. is a privately held biopharmaceutical company with its corporate office and headquarters located in San Diego, California, focused on restoring hope for patients.
Biotechnology
Arrivo BioVentures, LLC is a biopharmaceutical holding company that provides management oversight, funding, and intellectual property development for subsidiaries targeting hard-to-treat diseases. The company's clinical-stage pipeline includes drug candidates for major depressive disorder and severe acute pancreatitis.
Similar biotech company
HCW Biologics Inc. operates as a preclinical-stage biopharmaceutical firm, primarily engaged in the discovery and advancement of novel immunotherapies. Its research and development efforts are focused on addressing chronic, low-grade inflammation and a spectrum of age-related diseases. The company's leading therapeutic candidates include HCW9218, an injectable immunotherapeutic designed for patients with a variety of cancers, such as pancreatic, ovarian, breast, prostate, and colorectal, as well as for pulmonary fibrosis. Another key product, HCW9302, targets autoimmune conditions like alopecia areata and various metabolic disorders. Beyond these, HCW Biologics is also developing HCW9201, a cell-based therapy currently in Phase II clinical trials for the treatment of relapsed/refractory acute myeloid leukemia. Additionally, HCW9206 is under development specifically for acute myeloid leukemia. Incorporated in 2018, the company's corporate headquarters are situated in Miramar, Florida.
Similar biotech company
Rakuten Medical, Inc. is a global biotechnology company headquartered in San Diego, California, that develops precision, cell-targeting investigational therapies using its proprietary Alluminox technology platform.
Biotechnology
Carisma Therapeutics is a clinical-stage biotechnology company headquartered in Philadelphia, Pennsylvania, focused on discovering and developing engineered macrophage-based immunotherapies.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of CalciMedica, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for CalciMedica, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →